Pharmaceutical giants AstraZeneca and Merck said Thursday they had agreed a multi-billion-dollar deal to jointly develop key cancer drugs.
"The strategic collaboration is expected to further increase the number of treatment options available to patients," British company AstraZeneca and its US peer said in a statement.
Merck will pay AstraZeneca up to $8.5 billion (7.2 billion euros) under the deal struck to develop and commercialise the drugs.
GMT 11:41 2018 Tuesday ,23 January
UK regulator says Fox's Sky takeover 'not in public interest'GMT 07:47 2018 Monday ,15 January
UK construction firm Carillion liquidates businessGMT 14:22 2017 Thursday ,21 December
Ryanair says formally recognises pilots' unionGMT 06:27 2017 Thursday ,21 December
British prime minister's deputy resignsGMT 06:35 2017 Tuesday ,12 December
Brexit deal shows UK can leave EU in 'smooth and orderly' wayMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor